LYMPH-V: A wearable arm volume measurement device and mobile application for the prevention and early detection of breast cancer-related lymphedema: A study protocol
-
İsmail Toygar
,
Gülcan Bağçivan
,
Ayşe Arıkan Dönmez
,
Furkan Bilek
,
Çiğdem Fulya Dönmez
,
Pınar Borman
,
Mehmet Durmuş Çalışır
,
Yasin Karan
,
Elif Deniz Kaçmaz
Abstract
Background & Aim: Early detection of lymphedema is crucial to prevent progression to advanced stages that impair the quality of life in breast cancer survivors. This study aims to develop and evaluate LYMPH-V, a wearable arm volume measurement device and mobile application designed for the prevention and early detection of breast cancer-related lymphedema.
Methods & Materials: The study consists of two phases. In the first phase, the LYMPH-V wearable device and a supportive mobile application will be developed. The app will feature five core components: exercise modules, educational content, coping strategies, arm volume measurement/recording, and personalized reminders. Content will be created based on current guidelines and expert opinions. In the second phase, the effectiveness of the intervention will be assessed through a pilot randomized controlled trial, a reproducibility study, and usability evaluations. The device uses stretch sensors to monitor arm volume, and the mobile app provides alerts if measurements suggest early signs of lymphedema. Data will be stored securely and shared with healthcare professionals upon user approval.
Results: Expected outcomes include high usability, strong agreement with manual measurements, and improved capacity for at-home lymphedema monitoring and prevention.
Conclusion: LYMPH-V offers a promising digital solution that empowers survivors and healthcare providers through home-based arm volume tracking. This approach may facilitate early intervention, reduce healthcare burden, and enhance quality of life for breast cancer survivors.
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024;74(3):229-63. https://doi.org/10.3322/caac.21834
2. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA: A Cancer Journal for Clinicians. 2022;72(5):409-36. https://doi.org/10.3322/caac.21731
3. Anderson AS, Martin RM, Renehan AG, Cade J, Copson ER, Cross AJ, et al. Cancer survivorship, excess body fatness and weight-loss intervention-where are we in 2020? British Journal of Cancer. 2021;124(6):1057-65. https://doi.org/10.1038/s41416-020-01155-2
4. Gallicchio L, Tonorezos E, de Moor JS, Elena J, Farrell M, Green P, et al. Evidence gaps in cancer survivorship care: a report from the 2019 National Cancer Institute Cancer Survivorship Workshop. JNCI: Journal of the National Cancer Institute. 2021;113(9):1136-42. https://doi.org/10.1093/jnci/djab049
5. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660
6. Fu MR, Axelrod D, Guth AA, Cleland CM, Ryan CE, Weaver KR, et al. Comorbidities and quality of life among breast cancer survivors: A prospective study. Journal of Personalized Medicine. 2015;5(3):229-42. https://doi.org/10.3390/jpm5030229
7. Fu X, Lu Q, Pang D, Shen A, Shih Y-A, Wei X. Experiences of breast cancer survivors with lymphedema self-management: A systematic review of qualitative studies. Journal of Cancer Survivorship. 2023;17(3):619-33. https://doi.org/10.1007/s11764-022-01225-9
8. Carreira H, Williams R, Funston G, Stanway S, Bhaskaran K. Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom. PLoS Medicine. 2021;18(1):e1003504. https://doi.org/10.1371/journal.pmed.1003504
9. Taghian NR, Miller CL, Jammallo LS, O'Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: A review. Critical Reviews in Oncology/Hematology. 2014;92(3):227-34. https://doi.org/10.1016/j.critrevonc.2014.06.004
10. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clinic Proceedings. 2005;80(11):1480-4. https://doi.org/10.4065/80.11.1480
11. Gençay Can A, Ekşioğlu E, Çakçı FA. Early detection and treatment of subclinical lymphedema in patients with breast cancer. Lymphatic research and biology. 2019;17(3):368-73. https://doi.org/10.1089/lrb.2018.0033
12. Anbari AB, Wanchai A, Armer JM. Breast cancer-related lymphedema and quality of life: A qualitative analysis over years of survivorship. Chronic illness. 2021;17(3):257-68. https://doi.org/10.1177/1742395319872796
13. Sun Y, Shigaki CL, Armer JM. The influence of breast cancer related lymphedema on women's return-to-work. Women's Health. 2020;16:1745506520905720. https://doi.org/10.1177/1745506520905720
14. De Vrieze T, Nevelsteen I, Thomis S, De Groef A, Tjalma WA, Gebruers N, et al. What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Supportive Care in Cancer. 2020;28:439-49. https://doi.org/10.1007/s00520-019-05101-8
15. Lacomba MT, Sánchez MJY, Goñi ÁZ, Merino DP, del Moral OM, Téllez EC, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: Randomized, single-blinded, clinical trial. BMJ. 2010;340. https://doi.org/10.1136/bmj.b5396
16. McLaughlin K, Muldoon OT, Moutray M. Gender, gender roles and completion of nursing education: A longitudinal study. Nurse Education Today. 2010;30(4):303-7. https://doi.org/10.1016/j.nedt.2009.08.005
17. Lu S-R, Hong R-B, Chou W, Hsiao P-C. Role of physiotherapy and patient education in lymphedema control following breast cancer surgery. Therapeutics and Clinical Risk Management. 2015:319-27. https://doi.org/10.2147/TCRM.S77669
18. McLaughlin SA, DeSnyder SM, Klimberg S, Alatriste M, Boccardo F, Smith ML, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: Part 2: preventive and therapeutic options. Annals of Surgical Oncology. 2017;24:2827-35. https://doi.org/10.1245/s10434-017-5964-6
19. McLaughlin SA, Staley AC, Vicini F, Thiruchelvam P, Hutchison NA, Mendez J, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: Recommendations from a multidisciplinary expert ASBrS panel: Part 1: definitions, assessments, education, and future directions. Annals of Surgical Oncology. 2017;24:2818-26. https://doi.org/10.1245/s10434-017-5982-4
20. Choi JK, Kim HD, Sim YJ, Kim GC, Kim DK, Yu BC, et al. A survey of the status of awareness of lymphedema in breast cancer patients in Busan-Gyeongnam, Korea. Annals of Rehabilitation Medicine. 2015;39(4):609-15. https://doi.org/10.5535/arm.2015.39.4.609
21. Borman P, Yaman A, Yasrebi S, Özdemir O. The importance of awareness and education in patients with breast cancer-related lymphedema. Journal of Cancer Education. 2017;32:629-33. https://doi.org/10.1007/s13187-016-1026-1
22. Perdomo M, Davies C, Levenhagen K, Ryans K, Gilchrist L. Patient education for breast cancer-related lymphedema: A systematic review. Journal of Cancer Survivorship. 2023;17(2):384-98. https://doi.org/10.1007/s11764-022-01262-4
23. Johansson K, Hayes S. A historical account of the role of exercise in the prevention and treatment of cancer-related lymphedema. Lymphology. 2020;53(2):55-62. https://doi.org/10.2458/lymph.4655
24. Hayes SC, Singh B, Reul-Hirche H, Bloomquist K, Johansson K, Jönsson C, et al. The Effect of Exercise for the Prevention and Treatment of Cancer-related Lymphedema: A Systematic Review with Meta-analysis. Medicine and Science in Sports and Exercise. 2022; 54(8):1389-99. https://doi.org/10.1249/MSS.0000000000002918
25. Wu X, Liu Y, Zhu D, Wang F, Ji J, Yan H. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity lymphedema after operation of gynecologic cancer. Asian Journal of Surgery. 2021;44(1):111-5. https://doi.org/10.1016/j.asjsur.2020.03.022
26. Wanchai A, Armer JM. Effects of weight-lifting or resistance exercise on breast cancer-related lymphedema: A systematic review. International Journal of Nursing Sciences. 2019;6(1):92-8. https://doi.org/10.1016/j.ijnss.2018.12.006
27. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable. Medicine and Science in Sports and Exercise. 2019;51(11):2375-90. https://doi.org/10.1249/MSS.0000000000002116
28. Cal A, Bahar Z. Women's barriers to prevention of lymphedema after breast surgery and home care needs: A qualitative study. Cancer Nursing. 2016;39(6):E17-E25. https://doi.org/10.1097/NCC.0000000000000326
29. Ouyang Q, Li S, Gao M, Zhu L, Xu S, Meng S, et al. Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis. The Breast. 2021;57:36-42. https://doi.org/10.1016/j.breast.2021.02.012
30. Kapoor A, Nambisan P, Baker E. Mobile applications for breast cancer survivorship and self-management: A systematic review. Health Informatics Journal. 2020;26(4):2892-905. https://doi.org/10.1177/1460458220950853
31. Dahlke DV, Fair K, Hong YA, Beaudoin CE, Pulczinski J, Ory MG. Apps seeking theories: Results of a study on the use of health behavior change theories in cancer survivorship mobile apps. JMIR mHealth and uHealth. 2015;3(1):e3861. https://doi.org/10.2196/mhealth.3861
32. Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection: A prospective observational study. Lymphatic Research and Biology. 2014;12(4):289-94. https://doi.org/10.1089/lrb.2014.0035
33. Wei X, Lu Q, Jin S, Li F, Zhao Q, Cui Y, et al. Developing and validating a prediction model for lymphedema detection in breast cancer survivors. European Journal of Oncology Nursing. 2021;54:102023. https://doi.org/10.1016/j.ejon.2021.102023
34. Yamamoto T, Yamamoto N, Hara H, Mihara M, Narushima M, Koshima I. Upper extremity lymphedema index: A simple method for severity evaluation of upper extremity lymphedema. Annals of Plastic Surgery. 2013;70(1):47-49. https://doi.org/10.1097/SAP.0b013e3182275d23
35. Gjorup C, Zerahn B, Hendel HW. Assessment of volume measurement of breast cancer-related lymphedema by three methods: Circumference measurement, water displacement, and dual energy X-ray absorptiometry. Lymphatic Research and Biology. 2010;8(2):111-119. https://doi.org/10.1089/lrb.2009.0016
36. Chen YW, Tsai HJ, Hung HC, Tsauo JY. Reliability study of measurements for lymphedema in breast cancer patients. American Journal of Physical Medicine and Rehabilitation. 2008;87(1):33-38. https://doi.org/10.1097/PHM.0b013e31815b6199
37. Anik AR, Hasan K, Islam MM, Hasan MM, Ali MF, Das SK. Non-invasive portable technologies for monitoring breast cancer related lymphedema to facilitate telehealth: A scoping review. IEEE Journal of Biomedical and Health Informatics. 2023 May 29;27(9):4524-35. https://doi.org/10.1109/JBHI.2023.3280196
38. O'Brien B, Gisby T, Anderson IA, editors. Stretch sensors for human body motion. In: Electroactive Polymer Actuators and Devices (EAPAD); SPIE. 2014. 254-62. https://doi.org/10.1117/12.2046143
39. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Revista Panamericana de Salud Pública. 2015;38:506-514.
40. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346. https://doi.org/10.1136/bmj.e7586
41. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: Guided by information power. Qualitative Health Research. 2016;26(13):1753-60. https://doi.org/10.1177/1049732315617444
42. Moser A, Korstjens I. Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. European Journal of General Practice. 2018;24(1):9-18. https://doi.org/10.1080/13814788.2017.1375091
43. Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: A confidence interval approach. Journal of Clinical Epidemiology. 2013;66(2):197-201. https://doi.org/10.1016/j.jclinepi.2012.09.002
44. Danacıoğlu N, et al. "Yakınsamanın iki türü, zayıf büyük sayılar kanunu, merkezi limit teoremi ve ek sonuçlar [Two types of convergence, the weak law of large numbers, the central limit theorem, and additional results]." In Olasılığa giriş [Introduction to probability], 278–308. Ankara: Nobel Kitabevi, 2014.
45. Spielberger C. D. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
46. Ayaz A, Bilgin N, Mollaoğlu N. The Use of Stait-Trait Anxiety Inventory in Dental Anxiety Management. ADO Journal of Clinical Science. 2017;8(2):1553-60.
47. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. Journal of Clinical Oncology. 2006;24(18):2765-72. https://doi.org/10.1200/JCO.2005.03.6749
48. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. Journal of Clinical Oncology. 2007;25(28):4396-404. https://doi.org/10.1200/JCO.2006.08.2024
49. Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, et al. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Medicine and Science in Sports and Exercise. 2002;34(2):364-80. https://doi.org/10.1097/00005768-200202000-00027
50. Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1998;83(S12B):2821-7. https://doi.org/10.1002/(SICI)1097-0142(19981215)83:12B+<2821:AID-CNCR33>3.0.CO;2-G
51. Shoemaker SJ, Wolf MS, Brach C. Development of the Patient Education Materials Assessment Tool (PEMAT): A new measure of understandability and actionability for print and audiovisual patient information. Patient Education and Counseling. 2014;96(3):395-403. https://doi.org/10.1016/j.pec.2014.05.027
52. Orgun F, Paylan Akkoç C. Hasta eğitim materyallerinin değerlendirilmesi: okunabilirlik formülleri ve materyal değerlendirme araçları. Turkiye Klinikleri Journal of Nursing Sciences. 2020;12(3). https://doi.org/10.5336/nurses.2020-74172
53. Armer J. ONS Guidelines™ for cancer treatment-related lymphedema. Oncology Nursing Forum. 2020;47(5):518-38. https://doi.org/10.1188/20.ONF.518-538
54. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens‐Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. CA: A Cancer Journal for Clinicians. 2016;66(1):43-73. https://doi.org/10.3322/caac.21319
55. Torgbenu E, Luckett T, Buhagiar M, Phillips JL. Practice points for lymphoedema care in low- and middle-income countries developed by nominal group technique. BMC Health Services Research. 2023;23(1):1-13. https://doi.org/10.1186/s12913-023-09786-w
56. Charnock D, Shepperd S, Needham G, Gann R. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. Journal of Epidemiology and Community Health. 1999;53(2):105-11. https://doi.org/10.1136/jech.53.2.105
57. Gökdoğan F. Etkili bir hasta iletişimi için araç geliştirme: Yazılı materyallerin uygunluğunun değerlendirilmesi (DISCERN) [Tool development for effective patient communication: Evaluation of the suitability of written materials (DISCERN)]." Onkoloji Hemşireliği Derneği Bülteni (2003): 8-16.
58. Podleska LE, Poeppel T, Herbrik M, Dahlkamp L, Grabellus F, Taeger G. Drug dosage in isolated limb perfusion: Evaluation of a limb volume model for extremity volume calculation. World Journal of Surgical Oncology. 2014;12(1):1-9. https://doi.org/10.1186/1477-7819-12-81
59. Ochalek K, Gradalski T. Early detection of breast cancer-related lymphedema in the COVID-19 pandemic. Lymphatic Research and Biology. 2023;21(1):15-9. https://doi.org/10.1089/lrb.2021.0077
60. Hoehle H, Venkatesh V. Mobile application usability. MIS Quarterly. 2015;39(2):435-72. https://doi.org/10.25300/MISQ/2015/39.2.08
61. Çetin G. Mobil uygulama kullanılabilirliğini ve kullanımını incelemek için bir yapısal eşitlik modeli. Bilişim Teknolojileri Dergisi. 2019;12(3):169-81. https://doi.org/10.17671/gazibtd.454749
62. Temel E, Aşıkgarip N, Örnek K. Sağlıklı yetişkin bir popülasyonda koroid vaskülarite indeksi ölçümlerinin tekrarlanabilirliği ve yeniden üretilebilirliği. MN Ophthalmology/MN Oftalmoloji. 2022;29(1).
63. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77-101. https://doi.org/10.1191/1478088706qp063oa
64. Clarke V, Braun V. Thematic analysis: A practical guide. In: Thematic Analysis. 2021:1-100. https://doi.org/10.1007/978-3-319-69909-7_3470-2
65. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007;19(6):349-57. https://doi.org/10.1093/intqhc/mzm042
2. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA: A Cancer Journal for Clinicians. 2022;72(5):409-36. https://doi.org/10.3322/caac.21731
3. Anderson AS, Martin RM, Renehan AG, Cade J, Copson ER, Cross AJ, et al. Cancer survivorship, excess body fatness and weight-loss intervention-where are we in 2020? British Journal of Cancer. 2021;124(6):1057-65. https://doi.org/10.1038/s41416-020-01155-2
4. Gallicchio L, Tonorezos E, de Moor JS, Elena J, Farrell M, Green P, et al. Evidence gaps in cancer survivorship care: a report from the 2019 National Cancer Institute Cancer Survivorship Workshop. JNCI: Journal of the National Cancer Institute. 2021;113(9):1136-42. https://doi.org/10.1093/jnci/djab049
5. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660
6. Fu MR, Axelrod D, Guth AA, Cleland CM, Ryan CE, Weaver KR, et al. Comorbidities and quality of life among breast cancer survivors: A prospective study. Journal of Personalized Medicine. 2015;5(3):229-42. https://doi.org/10.3390/jpm5030229
7. Fu X, Lu Q, Pang D, Shen A, Shih Y-A, Wei X. Experiences of breast cancer survivors with lymphedema self-management: A systematic review of qualitative studies. Journal of Cancer Survivorship. 2023;17(3):619-33. https://doi.org/10.1007/s11764-022-01225-9
8. Carreira H, Williams R, Funston G, Stanway S, Bhaskaran K. Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom. PLoS Medicine. 2021;18(1):e1003504. https://doi.org/10.1371/journal.pmed.1003504
9. Taghian NR, Miller CL, Jammallo LS, O'Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: A review. Critical Reviews in Oncology/Hematology. 2014;92(3):227-34. https://doi.org/10.1016/j.critrevonc.2014.06.004
10. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clinic Proceedings. 2005;80(11):1480-4. https://doi.org/10.4065/80.11.1480
11. Gençay Can A, Ekşioğlu E, Çakçı FA. Early detection and treatment of subclinical lymphedema in patients with breast cancer. Lymphatic research and biology. 2019;17(3):368-73. https://doi.org/10.1089/lrb.2018.0033
12. Anbari AB, Wanchai A, Armer JM. Breast cancer-related lymphedema and quality of life: A qualitative analysis over years of survivorship. Chronic illness. 2021;17(3):257-68. https://doi.org/10.1177/1742395319872796
13. Sun Y, Shigaki CL, Armer JM. The influence of breast cancer related lymphedema on women's return-to-work. Women's Health. 2020;16:1745506520905720. https://doi.org/10.1177/1745506520905720
14. De Vrieze T, Nevelsteen I, Thomis S, De Groef A, Tjalma WA, Gebruers N, et al. What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Supportive Care in Cancer. 2020;28:439-49. https://doi.org/10.1007/s00520-019-05101-8
15. Lacomba MT, Sánchez MJY, Goñi ÁZ, Merino DP, del Moral OM, Téllez EC, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: Randomized, single-blinded, clinical trial. BMJ. 2010;340. https://doi.org/10.1136/bmj.b5396
16. McLaughlin K, Muldoon OT, Moutray M. Gender, gender roles and completion of nursing education: A longitudinal study. Nurse Education Today. 2010;30(4):303-7. https://doi.org/10.1016/j.nedt.2009.08.005
17. Lu S-R, Hong R-B, Chou W, Hsiao P-C. Role of physiotherapy and patient education in lymphedema control following breast cancer surgery. Therapeutics and Clinical Risk Management. 2015:319-27. https://doi.org/10.2147/TCRM.S77669
18. McLaughlin SA, DeSnyder SM, Klimberg S, Alatriste M, Boccardo F, Smith ML, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: Part 2: preventive and therapeutic options. Annals of Surgical Oncology. 2017;24:2827-35. https://doi.org/10.1245/s10434-017-5964-6
19. McLaughlin SA, Staley AC, Vicini F, Thiruchelvam P, Hutchison NA, Mendez J, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: Recommendations from a multidisciplinary expert ASBrS panel: Part 1: definitions, assessments, education, and future directions. Annals of Surgical Oncology. 2017;24:2818-26. https://doi.org/10.1245/s10434-017-5982-4
20. Choi JK, Kim HD, Sim YJ, Kim GC, Kim DK, Yu BC, et al. A survey of the status of awareness of lymphedema in breast cancer patients in Busan-Gyeongnam, Korea. Annals of Rehabilitation Medicine. 2015;39(4):609-15. https://doi.org/10.5535/arm.2015.39.4.609
21. Borman P, Yaman A, Yasrebi S, Özdemir O. The importance of awareness and education in patients with breast cancer-related lymphedema. Journal of Cancer Education. 2017;32:629-33. https://doi.org/10.1007/s13187-016-1026-1
22. Perdomo M, Davies C, Levenhagen K, Ryans K, Gilchrist L. Patient education for breast cancer-related lymphedema: A systematic review. Journal of Cancer Survivorship. 2023;17(2):384-98. https://doi.org/10.1007/s11764-022-01262-4
23. Johansson K, Hayes S. A historical account of the role of exercise in the prevention and treatment of cancer-related lymphedema. Lymphology. 2020;53(2):55-62. https://doi.org/10.2458/lymph.4655
24. Hayes SC, Singh B, Reul-Hirche H, Bloomquist K, Johansson K, Jönsson C, et al. The Effect of Exercise for the Prevention and Treatment of Cancer-related Lymphedema: A Systematic Review with Meta-analysis. Medicine and Science in Sports and Exercise. 2022; 54(8):1389-99. https://doi.org/10.1249/MSS.0000000000002918
25. Wu X, Liu Y, Zhu D, Wang F, Ji J, Yan H. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity lymphedema after operation of gynecologic cancer. Asian Journal of Surgery. 2021;44(1):111-5. https://doi.org/10.1016/j.asjsur.2020.03.022
26. Wanchai A, Armer JM. Effects of weight-lifting or resistance exercise on breast cancer-related lymphedema: A systematic review. International Journal of Nursing Sciences. 2019;6(1):92-8. https://doi.org/10.1016/j.ijnss.2018.12.006
27. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable. Medicine and Science in Sports and Exercise. 2019;51(11):2375-90. https://doi.org/10.1249/MSS.0000000000002116
28. Cal A, Bahar Z. Women's barriers to prevention of lymphedema after breast surgery and home care needs: A qualitative study. Cancer Nursing. 2016;39(6):E17-E25. https://doi.org/10.1097/NCC.0000000000000326
29. Ouyang Q, Li S, Gao M, Zhu L, Xu S, Meng S, et al. Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis. The Breast. 2021;57:36-42. https://doi.org/10.1016/j.breast.2021.02.012
30. Kapoor A, Nambisan P, Baker E. Mobile applications for breast cancer survivorship and self-management: A systematic review. Health Informatics Journal. 2020;26(4):2892-905. https://doi.org/10.1177/1460458220950853
31. Dahlke DV, Fair K, Hong YA, Beaudoin CE, Pulczinski J, Ory MG. Apps seeking theories: Results of a study on the use of health behavior change theories in cancer survivorship mobile apps. JMIR mHealth and uHealth. 2015;3(1):e3861. https://doi.org/10.2196/mhealth.3861
32. Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection: A prospective observational study. Lymphatic Research and Biology. 2014;12(4):289-94. https://doi.org/10.1089/lrb.2014.0035
33. Wei X, Lu Q, Jin S, Li F, Zhao Q, Cui Y, et al. Developing and validating a prediction model for lymphedema detection in breast cancer survivors. European Journal of Oncology Nursing. 2021;54:102023. https://doi.org/10.1016/j.ejon.2021.102023
34. Yamamoto T, Yamamoto N, Hara H, Mihara M, Narushima M, Koshima I. Upper extremity lymphedema index: A simple method for severity evaluation of upper extremity lymphedema. Annals of Plastic Surgery. 2013;70(1):47-49. https://doi.org/10.1097/SAP.0b013e3182275d23
35. Gjorup C, Zerahn B, Hendel HW. Assessment of volume measurement of breast cancer-related lymphedema by three methods: Circumference measurement, water displacement, and dual energy X-ray absorptiometry. Lymphatic Research and Biology. 2010;8(2):111-119. https://doi.org/10.1089/lrb.2009.0016
36. Chen YW, Tsai HJ, Hung HC, Tsauo JY. Reliability study of measurements for lymphedema in breast cancer patients. American Journal of Physical Medicine and Rehabilitation. 2008;87(1):33-38. https://doi.org/10.1097/PHM.0b013e31815b6199
37. Anik AR, Hasan K, Islam MM, Hasan MM, Ali MF, Das SK. Non-invasive portable technologies for monitoring breast cancer related lymphedema to facilitate telehealth: A scoping review. IEEE Journal of Biomedical and Health Informatics. 2023 May 29;27(9):4524-35. https://doi.org/10.1109/JBHI.2023.3280196
38. O'Brien B, Gisby T, Anderson IA, editors. Stretch sensors for human body motion. In: Electroactive Polymer Actuators and Devices (EAPAD); SPIE. 2014. 254-62. https://doi.org/10.1117/12.2046143
39. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Revista Panamericana de Salud Pública. 2015;38:506-514.
40. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346. https://doi.org/10.1136/bmj.e7586
41. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: Guided by information power. Qualitative Health Research. 2016;26(13):1753-60. https://doi.org/10.1177/1049732315617444
42. Moser A, Korstjens I. Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. European Journal of General Practice. 2018;24(1):9-18. https://doi.org/10.1080/13814788.2017.1375091
43. Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: A confidence interval approach. Journal of Clinical Epidemiology. 2013;66(2):197-201. https://doi.org/10.1016/j.jclinepi.2012.09.002
44. Danacıoğlu N, et al. "Yakınsamanın iki türü, zayıf büyük sayılar kanunu, merkezi limit teoremi ve ek sonuçlar [Two types of convergence, the weak law of large numbers, the central limit theorem, and additional results]." In Olasılığa giriş [Introduction to probability], 278–308. Ankara: Nobel Kitabevi, 2014.
45. Spielberger C. D. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
46. Ayaz A, Bilgin N, Mollaoğlu N. The Use of Stait-Trait Anxiety Inventory in Dental Anxiety Management. ADO Journal of Clinical Science. 2017;8(2):1553-60.
47. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. Journal of Clinical Oncology. 2006;24(18):2765-72. https://doi.org/10.1200/JCO.2005.03.6749
48. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. Journal of Clinical Oncology. 2007;25(28):4396-404. https://doi.org/10.1200/JCO.2006.08.2024
49. Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, et al. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Medicine and Science in Sports and Exercise. 2002;34(2):364-80. https://doi.org/10.1097/00005768-200202000-00027
50. Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1998;83(S12B):2821-7. https://doi.org/10.1002/(SICI)1097-0142(19981215)83:12B+<2821:AID-CNCR33>3.0.CO;2-G
51. Shoemaker SJ, Wolf MS, Brach C. Development of the Patient Education Materials Assessment Tool (PEMAT): A new measure of understandability and actionability for print and audiovisual patient information. Patient Education and Counseling. 2014;96(3):395-403. https://doi.org/10.1016/j.pec.2014.05.027
52. Orgun F, Paylan Akkoç C. Hasta eğitim materyallerinin değerlendirilmesi: okunabilirlik formülleri ve materyal değerlendirme araçları. Turkiye Klinikleri Journal of Nursing Sciences. 2020;12(3). https://doi.org/10.5336/nurses.2020-74172
53. Armer J. ONS Guidelines™ for cancer treatment-related lymphedema. Oncology Nursing Forum. 2020;47(5):518-38. https://doi.org/10.1188/20.ONF.518-538
54. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens‐Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. CA: A Cancer Journal for Clinicians. 2016;66(1):43-73. https://doi.org/10.3322/caac.21319
55. Torgbenu E, Luckett T, Buhagiar M, Phillips JL. Practice points for lymphoedema care in low- and middle-income countries developed by nominal group technique. BMC Health Services Research. 2023;23(1):1-13. https://doi.org/10.1186/s12913-023-09786-w
56. Charnock D, Shepperd S, Needham G, Gann R. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. Journal of Epidemiology and Community Health. 1999;53(2):105-11. https://doi.org/10.1136/jech.53.2.105
57. Gökdoğan F. Etkili bir hasta iletişimi için araç geliştirme: Yazılı materyallerin uygunluğunun değerlendirilmesi (DISCERN) [Tool development for effective patient communication: Evaluation of the suitability of written materials (DISCERN)]." Onkoloji Hemşireliği Derneği Bülteni (2003): 8-16.
58. Podleska LE, Poeppel T, Herbrik M, Dahlkamp L, Grabellus F, Taeger G. Drug dosage in isolated limb perfusion: Evaluation of a limb volume model for extremity volume calculation. World Journal of Surgical Oncology. 2014;12(1):1-9. https://doi.org/10.1186/1477-7819-12-81
59. Ochalek K, Gradalski T. Early detection of breast cancer-related lymphedema in the COVID-19 pandemic. Lymphatic Research and Biology. 2023;21(1):15-9. https://doi.org/10.1089/lrb.2021.0077
60. Hoehle H, Venkatesh V. Mobile application usability. MIS Quarterly. 2015;39(2):435-72. https://doi.org/10.25300/MISQ/2015/39.2.08
61. Çetin G. Mobil uygulama kullanılabilirliğini ve kullanımını incelemek için bir yapısal eşitlik modeli. Bilişim Teknolojileri Dergisi. 2019;12(3):169-81. https://doi.org/10.17671/gazibtd.454749
62. Temel E, Aşıkgarip N, Örnek K. Sağlıklı yetişkin bir popülasyonda koroid vaskülarite indeksi ölçümlerinin tekrarlanabilirliği ve yeniden üretilebilirliği. MN Ophthalmology/MN Oftalmoloji. 2022;29(1).
63. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77-101. https://doi.org/10.1191/1478088706qp063oa
64. Clarke V, Braun V. Thematic analysis: A practical guide. In: Thematic Analysis. 2021:1-100. https://doi.org/10.1007/978-3-319-69909-7_3470-2
65. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007;19(6):349-57. https://doi.org/10.1093/intqhc/mzm042
| Files | ||
| Issue | Vol 12 No 3 (2025): Summer | |
| Section | Original Article(s) | |
| Keywords | ||
| breast neoplasms; lymphedema; early diagnosis; mobile application; wearable electronic devices; self-management | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Toygar İsmail, Bağçivan G, Arıkan Dönmez A, Bilek F, Dönmez Çiğdem F, Borman P, Çalışır M, Karan Y, Deniz Kaçmaz E. LYMPH-V: A wearable arm volume measurement device and mobile application for the prevention and early detection of breast cancer-related lymphedema: A study protocol. NPT. 2025;12(3):259-274.
